Homeopathic treatment of seizures in childre

Phase 3

Completed

• Conditions: Health Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes

• Registration Number: CTRI/2018/10/016027
• Lead Sponsor: ational Institute of Homoeopathy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-05-28
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

a) Cases suffering from epilepsy for at least 3 months

b) Both male and female patients

c) Age between 4 and 18 years

d) Patients with seizure frequency of at least once in three months

e) Capability and willingness to give informed consent by the parents and to comply with the study procedures

f) Literate parents who can read English and/or Bengali

Exclusion Criteria

a) Patients with febrile convulsions

b) Patients with intractable epilepsy

c) Patients with co-morbidity, like - ADHD, mental retardation

d) A clinically significant acute or chronic disease that would hinder regular participation in the study

e) Patients who are not on anti-epileptic drugs

f) Complementary or alternative treatment used simultaneously to the study (for example acupuncture, psychotherapy etc.)

g) Homeopathic treatment for at least eight weeks for any chronic diseases

h) Cases suffering from uncontrolled systemic illness or life-threatening infections

i) Self-reported immune-compromised state

j) Patients with substance abuse and/or dependence

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hague Seizure Severity Scale (HASS) measures severity of childhood epilepsyTimepoint: At baseline, after 3 months, and after 6 months

Secondary Outcome Measures

Name	Time	Method
Pediatric Quality of Life Inventory (PedsQL) measures health-related quality of life (HRQOL) in healthy children and adolescents and those with acute and chronic health conditionsTimepoint: At baseline, after 3 months, and after 6 months;Quality of life in Childhood Epilepsy (QOLCE-16) measure of health-related quality of life (HRQoL)Timepoint: At baseline, after 3 months, and after 6 months